
On November 18, 2026, the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) launched its Joint Transnational Call 2027, committing approximately €31 million across 37 funding organisations in 27 countries to support collaborative research investigating antimicrobial resistance transmission dynamics across human, animal, and environmental ecosystems.
Consortium Funding and Transnational Scope
The call, titled “Understand, Model and Stop AMR Transmission,” marks the second annual joint call organized under EUP OHAMR. Co-funded by the European Commission under the Horizon Europe programme, the call pools national and regional budgets with EU matching funds. Financial support expanded substantially between planning and launch: preliminary notices in October 2026 estimated a €28 million envelope from 33 agencies, but final commitments reached €31 million from 37 organisations across 27 nations upon the formal November 18 opening.
Launched in June 2025 as a 10-year co-funded partnership, EUP OHAMR succeeds the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). While the 2026 call targeted clinical treatments and protocol adherence, the 2027 call tackles ecological transmission pathways and predictive modelling. The initiative coordinates research across four programmes: research funding, capacity strengthening, data exploitation, and policy impact. Consortia can leverage broader European mechanisms for research infrastructure funding to access harmonized surveillance platforms, repositories, and computational resources across participating borders.
Three Research Priorities: Modelling, Commensals, and Hotspots
Proposals must address Focus Area 1 (“Prevent the emergence and spread of AMR”) of the EUP OHAMR Strategic Research and Innovation Agenda, selecting exactly one of three core topics:
- Topic 1: Model AMR transmission dynamics to predict emergence and spread for public authorities. Projects must develop transmission models across One Health settings to forecast antibiotic and antifungal resistance emergence. Models must incorporate anthropogenic drivers (such as agricultural practices, trade, migration, armed conflict, and travel) alongside climate shocks (such as heatwaves and floods). These tools aim to identify intervention points for public authorities, drawing on epidemiological scenario modelling to guide regulatory policy.
- Topic 2: Understand host commensal micro-organisms in AMR dynamics and develop selective decolonisation tools. Commensal bacteria and fungi in humans and animals act as hidden reservoirs for resistance genes. Projects must examine transmission between commensals and pathogens, developing targeted solutions to decolonise resistant reservoir strains without disrupting protective microbiota.
- Topic 3: Reduce resistant bacteria, fungi, and resistance genes in environmental hotspots. Hotspots include wastewater treatment plants, hospital effluent pipelines, pharmaceutical manufacturing discharges, and agricultural manure storage. Proposals must test innovative decontamination solutions and measure their epidemiological impact across at least two One Health domains, mandating both human and environmental settings.
Proposals must establish practical feasibility, clear pathways to societal uptake, and transnational value. Participation by industry, start-ups, and small and medium-sized enterprises (SMEs) is encouraged across all topics.
Consortium Architecture and Eligibility Rules
To qualify, international consortia must comprise at least three eligible partners requesting funding from three different participating countries, including at least two based in EU Member States or Horizon Europe Associated Countries. Standard consortia may include up to six partners, encompassing funded institutions and self-funded external collaborators.
Consortia can expand their ceiling to seven partners by meeting at least one strategic criterion: including a partner from an under-represented country (Czech Republic, Hungary, Latvia, Lithuania, Malta, Moldova, Poland, or Slovakia); a Principal Investigator who is an early-career researcher; or an active industry partner or SME. Furthermore, no single funding organisation may fund more than two partners in the same consortium.
Each consortium must designate a project coordinator in a grant consortium to act as the single point of contact with the Joint Call Secretariat. Participating institutional partners in a grant consortium must submit signed letters of intent at both pre-proposal and full proposal stages. Grantees must also establish a formal consortium agreement governing intellectual property, data sharing, and decision-making prior to project launch.
Under EU restrictive measures, legal entities established in Russia, Belarus, or non-government-controlled territories of Ukraine, as well as entities majority-owned by Russian legal persons, are strictly barred from participating in any capacity.
Key Deadlines and Evaluation Milestones
The call operates a two-stage competitive submission process via the centralised PT Outline portal. The table below details key milestone dates:
| Milestone Stage | Calendar Date | Operational Requirement |
|---|---|---|
| Call Launch | November 18, 2026 | Official call publication and PT Outline submission platform opens |
| Applicant Information Webinar | November 25, 2026 (13:30 CET) | Online briefing for prospective coordinators and partner networking |
| Pre-Proposal Deadline | February 1, 2027 (13:00 CET) | Submission of outline proposals, PIC codes, and signed letters of intent |
| Stage 1 Assessment Results | May 5, 2027 | Joint Call Secretariat communicates pre-proposal outcomes by email |
| Full Proposal Deadline | June 23, 2027 (13:00 CET) | Invited consortia submit full technical proposals and workpackages |
| Final Funding Decision | November 4, 2027 | Secretariat sends final funding recommendations to project coordinators |
| Public Results Announcement | November 2027 | Award announcements published during World AMR Awareness Week |
| Project Start Window | December 2027 – April 2028 | Consortium agreements signed; 3-year research projects commence |
Principal Investigators face strict limits: an individual researcher may apply for at most two proposals across the call, serving as coordinator on at most one.
National Funder Rules and Dual Submission Platforms
Because EUP OHAMR is a co-funded partnership rather than a single European Commission grant, financial allocations are governed by national eligibility rules and domestic cost reimbursement rates rather than uniform Horizon Europe terms. Programme intelligence tracked by Grantsby emphasizes that participating agencies enforce independent budget caps, overhead allowances, and eligible cost structures.
Several participating countries impose specific operational constraints:
- The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw) limits Dutch funding eligibility exclusively to Topic 1 (transmission modelling) and Topic 3 (environmental hotspots). Dutch applicants must also satisfy national state-aid status rules for research organisations.
- Sweden: The Swedish Research Council (Vetenskapsrådet) provides a minimum grant of 1.2 million SEK (approximately €110,000) per Swedish partner and a maximum of 3.5 million SEK (approximately €321,000) per project for up to two Swedish partners, plus an additional 500,000 SEK (approximately €45,000) coordination allowance. Swedish applicants must complete a mandatory parallel application within Sweden’s Prisma system by February 8, 2027, one week after the central pre-proposal closure.
- United Kingdom: UK researchers participate via the Medical Research Council (MRC), the Department of Health and Social Care (DHSC), and Innovate UK, each applying specific remit boundaries and cost structures.
- France and Germany: The Agence Nationale de la Recherche (ANR) and German federal agencies manage domestic eligibility, with the overall Joint Call Secretariat administered by the German DLR Project Management Agency in Bonn.
Operational Guidance for Research Offices and Principal Investigators
University research administration offices and prospective applicants should prepare several administrative requirements ahead of the February 2027 pre-proposal deadline:
- Participant Identification Codes (PIC): All participating academic departments, clinical bodies, and industry partners must obtain a validated PIC through the European Commission Funding & Tenders Opportunities portal. Pre-proposals cannot be submitted in PT Outline without valid PICs for all consortium members.
- Partner Matching Platforms: Consortia should utilize the official EUP OHAMR Partner Search Tool early. Recruiting partners from Central and Eastern European nations or early-career researchers directly secures the expanded seven-partner consortium allowance.
- Monitoring Dual Portals: Research offices must monitor domestic submission portals alongside PT Outline. As with Sweden’s Prisma deadline on February 8, 2027, several national agencies require parallel domestic filings and institutional authorisations shortly after the central deadline.
- Pre-Submission Eligibility Inquiries: Because national agencies can declare domestic partners ineligible—risking the disqualification of the entire consortium—applicants must instruct each partner to contact their national contact point to confirm budget rules, eligible overheads, and clinical or environmental scopes prior to submission.
- Webinar Registration: Prospective coordinators and partners should register for the Secretariat’s applicant briefing webinar on November 25, 2026 at 13:30 CET, which will cover application mechanics and consortium criteria.
Sources
- European Partnership on One Health Antimicrobial Resistance: Joint transnational call 2027 – EUP OHAMR, checked 2026-11-21
- ZonMw: Pre-announcement grant call: Understand, Model and Stop AMR Transmission, checked 2026-11-21
- Swedish Research Council: Project grant for international research collaboration within antimicrobial resistance (EUP OHAMR) – Swedish Research Council, checked 2026-11-21
- Grantsby: Joint Transnational Call 2027 – Understand, Model and Stop AMR Transmission | Grantsby, checked 2026-11-21







